SCHEMBL12809824

SCHEMBL12809824

C=Cc1cc(OC)ccc1BC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.41
▸ CYP1A1 P04798 7/20 0.40
▸ CYP1B1 Q16678 7/20 0.40
▸ CYP1A2 P05177 7/20 0.40
▸ NFE2L2 Q16236 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ NQO2 P16083 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TRIM24 O15164 1/20 0.37
▸ TYR P14679 1/20 0.37
▸ TRIM33 Q9UPN9 1/20 0.37
▸ JUN P05412 1/20 0.37
▸ NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30567454 0.78 CYP1A2 (0.52) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL9065566 0.78 CYP1A2 (0.52) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL1792533 0.75 CYP1A1 (0.61) CYP1A1CYP1B1CYP1A2NFE2L2ALDH1A1
SCHEMBL11986284 0.75 ERN1 (0.44) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL4025438 0.75 ERN1 (0.44) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL14613174 0.73 ERN1 (0.67) ERN1CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL16310056 0.73 ERN1 (0.43) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL5440523 0.73 ALDH1A1 (0.43) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL825091 0.73 ERN1 (0.43) ERN1CYP1A1CYP1B1CYP1A2NFE2L2
SCHEMBL5442396 0.73 NFE2L2 (0.49) ERN1CYP1A1CYP1B1CYP1A2NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2024375-B1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2011-03-09 — — EP disclosed
Send feedback